Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sulphur hexafluoride-stabilized microbubbles are tiny gas-filled spheres encapsulated by a stabilizing shell (lipid, protein, or polymer) injected intravenously as agents for contrast-enhanced ultrasound imaging. They dramatically increase ultrasound reflectivity—thus enhancing visualization of blood flow and tissue vascularity in imaging modalities. When exposed to ultrasound waves, these microbubbles oscillate, resonate, and can collapse (cavitation), generating local bioeffects, which have been exploited for experimental drug and gene delivery, and for transient opening of structures like the blood-brain barrier. They are not biological targets but rather engineered agents for diagnosis and therapy
Enhance ultrasound imaging by nonlinear resonance and increased echogenicity; mediate delivery via sonoporation (increased membrane permeability from ultrasound-induced microbubble destruction)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulphur hexafluoride-stabilized microbubble (ultrasound contrast agent) (None in standard scientific usage; sometimes abbreviated in product names (e.g., SF6 microbubbles), but no universal canonical abbreviation.).